School of Chemical Engineering and Advanced Materials-CEAM, Newcastle University, Merz Court, Newcastle upon Tyne NE1 7RU, UK.
J Ind Microbiol Biotechnol. 2013 May;40(5):477-87. doi: 10.1007/s10295-013-1238-x. Epub 2013 Mar 2.
Polyunsaturated fatty acids (PUFAs), especially eicosapentaenoic acid (EPA), are increasingly attracting scientific attention owing to their significant health-promoting role in the human body. However, the human body lacks the ability to produce them in vivo. The limitations associated with the current sources of ω-3 fatty acids from animal and plant sources have led to increased interest in microbial production. Bacterial isolate 717 was identified as a potential high EPA producer. As an important step in the process development of the microbial PUFA production, the culture conditions at the bioreactor scale were optimised for the isolate 717 using a response surface methodology exploring the significant effect of temperature, pH and dissolved oxygen and the interaction between them on the EPA production. This optimisation strategy led to a significant increase in the amount of EPA produced by the isolate under investigation, where the amount of EPA increased from 9 mg/g biomass (33 mg/l representing 7.6 % of the total fatty acids) to 45 mg/g (350 mg/l representing 25 % of the total fatty acids). To avoid additional costs associated with extreme cooling at large scale, a temperature shock experiment was carried out reducing the overall cooling time from the whole cultivation process to 4 h only prior to harvest. The ability of the organism to produce EPA under the complete absence of oxygen was tested revealing that oxygen is not critically required for the biosynthesis of EPA but the production improved in the presence of oxygen. The stability of the produced oil and the complete absence of heavy metals in the bacterial biomass are considered as an additional benefit of bacterial EPA compared to other sources of PUFA. To our knowledge this is the first report of a bacterial isolate producing EPA with such high yields making the large-scale manufacture much more economically viable.
多不饱和脂肪酸(PUFAs),尤其是二十碳五烯酸(EPA),由于其在人体中具有重要的促进健康作用,因此越来越受到科学界的关注。然而,人体缺乏在体内产生它们的能力。当前从动物和植物来源获得ω-3 脂肪酸的来源存在局限性,这导致人们对微生物生产越来越感兴趣。细菌分离株 717 被鉴定为具有生产高 EPA 的潜力。作为微生物 PUFA 生产过程开发的重要步骤,使用响应面法对生物反应器规模下的培养条件进行了优化,该方法探讨了温度、pH 和溶解氧的显著影响以及它们之间的相互作用对 EPA 生产的影响。这种优化策略导致被研究的分离株产生的 EPA 量显著增加,其中 EPA 的量从 9mg/g 生物质(代表总脂肪酸的 7.6%,33mg/l)增加到 45mg/g(代表总脂肪酸的 25%,350mg/l)。为了避免在大规模生产中因极端冷却而产生额外成本,进行了温度冲击实验,仅在收获前将整个培养过程的总冷却时间从 4 小时减少到 4 小时。测试了该生物体在完全没有氧气的情况下生产 EPA 的能力,结果表明氧气不是 EPA 生物合成的关键,但在存在氧气的情况下生产会得到改善。与其他 PUFA 来源相比,细菌 EPA 的生产油的稳定性和细菌生物质中完全不存在重金属被认为是其额外的优势。据我们所知,这是第一个报告生产 EPA 产量如此之高的细菌分离株的报告,这使得大规模生产更具经济可行性。